Genetic variation at the calcium-sensing receptor (CASR) locus: Implications for clinical molecular diagnostics

Clinical Biochemistry

Volumn 40, Issue 8, 2007, Pages 551-561

  Yun, Francisco H J ^a   Wong, Betty Y L ^b   Chase, Maretta ^c   Shuen, Andrew Y ^a   Canaff, Lucie ^d   Thongthai, Kansuda ^d   Siminovitch, Katherine ^a,c,e,f   Hendy, Geoffrey N ^d   Cole, David E C ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Calcium sensing receptor; Haplotype block; Hypercalcaemia; Hypocalcaemia; Molecular diagnostics; Single nucleotide polymorphism

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR;

AFRICAN AMERICAN; ARTICLE; ASIAN; CAUCASIAN; CHROMOSOME; COHORT ANALYSIS; DIAGNOSTIC PROCEDURE; DNA POLYMORPHISM; EXON; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; KNOWLEDGE; LABORATORY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERCALCEMIA; HYPOCALCEMIA; LINKAGE DISEQUILIBRIUM; MODELS, GENETIC; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCIUM-SENSING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VARIATION (GENETICS);

EID: 34247371110     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.12.011     Document Type: Article

References (53)

1. 2+-sensing receptor from bovine parathyroid. Nature 366 (1993) 575-580
2. Thompson M.D., Burnham W.M., and Cole D.E.C. The G protein-coupled receptors: pharmacogenetics and disease. Crit. Rev. Clin. Lab. Sci. 42 (2005) 311-392
3. Brown E.M. The pathophysiology of primary hyperparathyroidism. J. Bone Miner. Res. 17 Suppl. 2 (2002) N24-N29
4. 2+-sensing receptor gene cause familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. Cell 75 (1993) 1297-1303
5. Hendy G.N., D'Souza-Li L., Yang B., Canaff L., and Cole D.E.C. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcaemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcaemia. Hum. Mutat. 16 (2000) 281-296
6. Thakker R.V. Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 35 (2004) 275-282
7. 2+-sensing receptor gene mutation. Nat. Genet. 8 (1994) 303-307
8. Pidasheva S., D'Souza-Li L., Canaff L., Cole D.E.C., and Hendy G.N. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcaemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcaemia. Hum. Mutat. 24 (2004) 107-111
9. Kifor O., Moore Jr. F.D., Delaney M., Garber J., Hendy G.N., Butters R., et al. A syndrome of hypocalciuric hypercalcaemia caused by autoantibodies directed at the calcium-sensing receptor. J. Clin. Endocrinol. Metab. 88 (2003) 60-72
10. Kifor O., McElduff A., LeBoff M.S., Moore Jr. F.D., Butters R., Gao P., et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism . J. Clin. Endocrinol. Metab. 89 (2004) 548-556
11. 2+-sensing receptor cDNA from human kidney. Biochem. Biophys. Res. Commun. 214 (1995) 524-529
12. Garrett J.E., Capuano I.V., Hammerland L.G., Hung B.C., Brown E.M., Hebert S.C., et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J. Biol. Chem. 270 (1995) 12919-12925
13. Chikatsu N., Fukumoto S., Takeuchi Y., Suzawa M., Obara T., Matsumoto T., et al. Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. J. Biol. Chem. 275 (2000) 7553-7557
14. Canaff L., and Hendy G.N. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J. Biol. Chem. 277 (2002) 30337-30350
15. Heath III H., Odelberg S., Jackson C.E., Teh B.T., Hayward N., Larsson C., et al. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcaemia suggest receptor functional domains. J. Clin. Endocrinol. Metab. 81 (1996) 1312-1317
16. Scillitani A., Guarnieri V., De Geronimo S., Muscarella L.A., Battista C., Agruma D.'L., et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J. Clin. Endocrinol. Metab. 89 (2004) 5634-5638
17. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
18. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., and Lander E.S. High-resolution haplotype structure in the human genome. Nat. Genet. 29 (2001) 229-232
19. Patil N., Berno A.J., Hinds D.A., Barrett W.A., Doshi J.M., Hacker C.R., et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294 (2001) 1719-1723
20. Haiman C.A., Stram D.O., Pike M.C., Kolonel L.N., Burtt N.P., Altshuler D., et al. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the multiethnic cohort. Hum. Mol. Genet. 12 (2003) 2679-2692
21. Rubin L.A., Hawker G.A., Peltekova V.D., Fielding L.J., Ridout R., and Cole D.E.C. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J. Bone Miner. Res. 14 (1999) 633-643
22. Janicic N., Soliman E., Pausova Z., Seldin M.F., Riviere M., Szpirer J., et al. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm. Genome 6 (1995) 798-801
23. Canaff L., and Hendy G.N. Calcium-sensing receptor gene transcription is up-regulated by the pro-inflammatory cytokine, interleukin-1beta. Role of the NF-kappaB pathway and kappaB elements. J. Biol. Chem. 280 (2005) 14177-14188
24. Haga H., Yamada R., Ohnishi Y., Nakamura Y., and Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190562 genetic variations in the human genome. J. Hum. Genet. 47 (2002) 605-610
25. Tang K., Fu D.J., Julien D., Braun A., Cantor C.R., and Koster H. Chip-based genotyping by mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10016-10020
26. Hamilton D.C., and Cole D.E.C. Standardizing a composite measure of linkage disequilibrium. Ann. Hum. Genet. 68 (2004) 234-239
27. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
28. Qin Z.S., Niu T., and Liu J.S. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet. 71 (2002) 1242-1247
29. Pidasheva S., Canaff L., Simonds W.F., Marx S.J., and Hendy G.N. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcaemia. Hum. Mol. Genet. 14 (2005) 1679-1690
30. Simonds W.F., James-Newton L.A., Agarwal S.K., Yang B., Skarulis M.C., Hendy G.N., et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine 81 (2002) 1-26
31. Wystrychowski A., Pidasheva S., Canaff L., Chudek J., Kokot F., Wiecek A., et al. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcaemia or neonatal hyperparathyroidism. J. Clin. Endocrinol. Metab. 90 (2005) 864-870
32. Cetani F., Pinchera A., Pardi E., Cianferotti L., Vignali E., Picone A., et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J. Bone Miner. Res. 14 (1999) 878-882
33. 2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum. Mol. Genet. 5 (1996) 601-606
34. D'Souza-Li L., Canaff L., Janicic N., Cole D.E., and Hendy G.N. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. Hum. Mutat. 18 (2001) 411-421
35. Hinds D.A., Stuve L.L., Nilsen G.B., Halperin E., Eskin E., Ballinger D.G., et al. Whole-genome patterns of common DNA variation in three human populations. Science 307 (2005) 1072-1079
36. Pratt J.H., Ambrosius W.T., Wagner M.A., and Maharry K. Molecular variations in the calcium-sensing receptor in relation to sodium balance and presence of hypertension in blacks and whites. Am. J. Hypertens. 13 (2000) 654-658
37. Takacs I., Speer G., Bajnok E., Tabak A., Nagy Z., Horvath C., et al. Lack of association between calcium-sensing receptor gene "A986S" polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 30 (2002) 849-852
38. Peters U., Chatterjee N., Yeager M., Chanock S.J., Schoen R.E., McGlynn K.A., et al. Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol., Biomarkers Prev. 13 (2004) 2181-2186
39. 2+-sensing receptor gene in Japanese individuals: no relation to non-insulin dependent diabetes mellitus. Horm. Metab. Res. 28 (1996) 541-544
40. Cole D.E.C., Peltekova V.D., Rubin L.A., Hawker G.A., Vieth R., Liew C.C., et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 353 (1999) 112-115
41. Cole D.E.C., Vieth R., Trang H.M., Wong B.Y., Hendy G.N., and Rubin L.A. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol. Genet. Metab. 72 (2001) 168-174
42. Lorentzon M., Lorentzon R., Lerner U.H., and Nordstrom P. Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Eur. J. Endocrinol. 144 (2001) 257-261
43. Miedlich S., Lamesch P., Mueller A., and Paschke R. Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 145 (2001) 421-427
44. Yamauchi M., Sugimoto T., Yamaguchi T., Yano S., Kanzawa M., Kobayashi A., et al. Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 55 (2001) 373-379
45. Cetani F., Borsari S., Vignali E., Pardi E., Picone A., Cianferotti L., et al. Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism. J. Endocrinol. Invest. 25 (2002) 614-619
46. Bollerslev J., Wilson S.G., Dick I.M., Devine A., Dhaliwal S.S., and Prince R.L. Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women. Calcif. Tissue Int. 74 (2004) 12-17
47. Petrucci M., Scott P., Ouimet D., Trouve M.L., Proulx Y., Valiquette L., et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int. 58 (2000) 38-42
48. Young R., Wu F., Van de Water N., Ames R., Gamble G., and Reid I.R. Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women. J. Clin. Endocrinol. Metab. 88 (2003) 697-700
49. Moore M., Koo B., and Levine M.A. Calcium-sensing receptor gene polymorphisms are not associated with an increased risk of developing primary hyperparathyroidism. J. Bone Miner. Res. 11 (1996) T473
50. Scillitani A., Guarnieri V., Battista C., De Geronimo S., Muscarella L.A., Chiodini I., et al. Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. J. Clin. Endocrinol. Metab. 92 (2007) 277-283
51. Cole D.E.C., Trang H.M., Vieth R., Peltekova V.D., Pierratos A., Wong B.Y., et al. Calcium excretion is independently associated with the vitamin D receptor (VDR) and calcium-sensing receptor (CASR) polymorphisms in a nephrolithiasis population. Bone 23 Suppl. 1 (1998) S248
52. Vezzoli G., Tanini A., Ferrucci L., Soldati L., Bianchin C., Franceschelli F., et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J. Am. Soc. Nephrol. 13 (2002) 2517-2523
53. Hattersley A.T., and McCarthy M.I. What makes a good genetic association study?. Lancet 366 (1995) 1315-1323